STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies

Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicologic pathology 2018-06, Vol.46 (4), p.372-402
Hauptverfasser: Bolon, Brad, Krinke, Georg, Butt, Mark T., Rao, Deepa B., Pardo, Ingrid D., Jortner, Bernard S., Garman, Robert H., Jensen, Karl, Andrews-Jones, Lydia, Morrison, James P., Sharma, Alok K., Thibodeau, Michael S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 402
container_issue 4
container_start_page 372
container_title Toxicologic pathology
container_volume 46
creator Bolon, Brad
Krinke, Georg
Butt, Mark T.
Rao, Deepa B.
Pardo, Ingrid D.
Jortner, Bernard S.
Garman, Robert H.
Jensen, Karl
Andrews-Jones, Lydia
Morrison, James P.
Sharma, Alok K.
Thibodeau, Michael S.
description Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four different situations encountered during nonclinical general toxicity (screening) and dedicated neurotoxicity studies. For toxicity studies where neurotoxicity is unknown or not anticipated (situation 1), PNS evaluation may be limited to one sensorimotor spinal nerve. If somatic PNS neurotoxicity is suspected (situation 2), analysis minimally should include three spinal nerves, multiple dorsal root ganglia, and a trigeminal ganglion. If autonomic PNS neuropathy is suspected (situation 3), parasympathetic and sympathetic ganglia should be assessed. For dedicated neurotoxicity studies where a neurotoxic effect is expected (situation 4), PNS sampling follows the strategy for situations 2 and/or 3, as dictated by functional or other compound/target-specific data. For all situations, bilateral sampling with unilateral processing is acceptable. For situations 1–3, PNS is processed conventionally (immersion in buffered formalin, paraffin embedding, and hematoxylin and eosin staining). For situation 4 (and situations 2 and 3 if resources and timing permit), perfusion fixation with methanol-free fixative is recommended. Where PNS neurotoxicity is suspected or likely, at least one (situations 2 and 3) or two (situation 4) nerve cross sections should be postfixed with glutaraldehyde and osmium before hard plastic resin embedding; soft plastic embedding is not a suitable substitute for hard plastic. Special methods may be used if warranted to further characterize PNS findings. Initial PNS analysis should be informed, not masked (“blinded”). Institutions may adapt these recommendations to fit their specific programmatic requirements but may need to explain in project documentation the rationale for their chosen PNS sampling, processing, and evaluation strategy.
doi_str_mv 10.1177/0192623318772484
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2043181517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0192623318772484</sage_id><sourcerecordid>2043181517</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-8eb297655085df001410678fedb40625d260a4c4a489c2ae41941ae88f471d43</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EotvCnRPysUgN2IkTO9zaCgpSVSKy98hrT7auYjvYDmIfkPfCYQsHJE72zPzzjWZ-hF5R8pZSzt8R2pZNWVVUcF4ywZ6gDa2rqqANoU_RZi0Xa_0Encb4QAgVlJHn6KRsueAV4xv0s992uPPRJOMd7uQM4T3-CspbC06DxlcQE-6CVMkoiHj0AffSzpNx-4uc9zkZf_-l0_jSyekQTcR-xOkecAfBzPcQ5ITvIHz3S8T9ISaw-HyNM2_t6r2VmX4kLMk7b3N0I91-MvIN1kvIA_CddypPNSrDtv6HUSYdcJ8WbSC-QM9GOUV4-fieoe3HD9vrT8Xtl5vP15e3hap4mwoBu7x5U9dE1HrM52CUNFyMoHeMNGWty4ZIpphkolWlBEZbRiUIMTJONavO0PkROwf_bcmHGayJCqZJOsi7DSVh2QpaU56l5ChVwccYYBzmYKwMh4GSYfVu-Ne73PL6kb7sLOi_DX_MyoLiKIhyD8ODX0I-d_w_8BfOqaMc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2043181517</pqid></control><display><type>article</type><title>STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies</title><source>SAGE Complete</source><source>Alma/SFX Local Collection</source><creator>Bolon, Brad ; Krinke, Georg ; Butt, Mark T. ; Rao, Deepa B. ; Pardo, Ingrid D. ; Jortner, Bernard S. ; Garman, Robert H. ; Jensen, Karl ; Andrews-Jones, Lydia ; Morrison, James P. ; Sharma, Alok K. ; Thibodeau, Michael S.</creator><creatorcontrib>Bolon, Brad ; Krinke, Georg ; Butt, Mark T. ; Rao, Deepa B. ; Pardo, Ingrid D. ; Jortner, Bernard S. ; Garman, Robert H. ; Jensen, Karl ; Andrews-Jones, Lydia ; Morrison, James P. ; Sharma, Alok K. ; Thibodeau, Michael S.</creatorcontrib><description>Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four different situations encountered during nonclinical general toxicity (screening) and dedicated neurotoxicity studies. For toxicity studies where neurotoxicity is unknown or not anticipated (situation 1), PNS evaluation may be limited to one sensorimotor spinal nerve. If somatic PNS neurotoxicity is suspected (situation 2), analysis minimally should include three spinal nerves, multiple dorsal root ganglia, and a trigeminal ganglion. If autonomic PNS neuropathy is suspected (situation 3), parasympathetic and sympathetic ganglia should be assessed. For dedicated neurotoxicity studies where a neurotoxic effect is expected (situation 4), PNS sampling follows the strategy for situations 2 and/or 3, as dictated by functional or other compound/target-specific data. For all situations, bilateral sampling with unilateral processing is acceptable. For situations 1–3, PNS is processed conventionally (immersion in buffered formalin, paraffin embedding, and hematoxylin and eosin staining). For situation 4 (and situations 2 and 3 if resources and timing permit), perfusion fixation with methanol-free fixative is recommended. Where PNS neurotoxicity is suspected or likely, at least one (situations 2 and 3) or two (situation 4) nerve cross sections should be postfixed with glutaraldehyde and osmium before hard plastic resin embedding; soft plastic embedding is not a suitable substitute for hard plastic. Special methods may be used if warranted to further characterize PNS findings. Initial PNS analysis should be informed, not masked (“blinded”). Institutions may adapt these recommendations to fit their specific programmatic requirements but may need to explain in project documentation the rationale for their chosen PNS sampling, processing, and evaluation strategy.</description><identifier>ISSN: 0192-6233</identifier><identifier>EISSN: 1533-1601</identifier><identifier>DOI: 10.1177/0192623318772484</identifier><identifier>PMID: 29787347</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><ispartof>Toxicologic pathology, 2018-06, Vol.46 (4), p.372-402</ispartof><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-8eb297655085df001410678fedb40625d260a4c4a489c2ae41941ae88f471d43</citedby><cites>FETCH-LOGICAL-c379t-8eb297655085df001410678fedb40625d260a4c4a489c2ae41941ae88f471d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0192623318772484$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0192623318772484$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29787347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bolon, Brad</creatorcontrib><creatorcontrib>Krinke, Georg</creatorcontrib><creatorcontrib>Butt, Mark T.</creatorcontrib><creatorcontrib>Rao, Deepa B.</creatorcontrib><creatorcontrib>Pardo, Ingrid D.</creatorcontrib><creatorcontrib>Jortner, Bernard S.</creatorcontrib><creatorcontrib>Garman, Robert H.</creatorcontrib><creatorcontrib>Jensen, Karl</creatorcontrib><creatorcontrib>Andrews-Jones, Lydia</creatorcontrib><creatorcontrib>Morrison, James P.</creatorcontrib><creatorcontrib>Sharma, Alok K.</creatorcontrib><creatorcontrib>Thibodeau, Michael S.</creatorcontrib><title>STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies</title><title>Toxicologic pathology</title><addtitle>Toxicol Pathol</addtitle><description>Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four different situations encountered during nonclinical general toxicity (screening) and dedicated neurotoxicity studies. For toxicity studies where neurotoxicity is unknown or not anticipated (situation 1), PNS evaluation may be limited to one sensorimotor spinal nerve. If somatic PNS neurotoxicity is suspected (situation 2), analysis minimally should include three spinal nerves, multiple dorsal root ganglia, and a trigeminal ganglion. If autonomic PNS neuropathy is suspected (situation 3), parasympathetic and sympathetic ganglia should be assessed. For dedicated neurotoxicity studies where a neurotoxic effect is expected (situation 4), PNS sampling follows the strategy for situations 2 and/or 3, as dictated by functional or other compound/target-specific data. For all situations, bilateral sampling with unilateral processing is acceptable. For situations 1–3, PNS is processed conventionally (immersion in buffered formalin, paraffin embedding, and hematoxylin and eosin staining). For situation 4 (and situations 2 and 3 if resources and timing permit), perfusion fixation with methanol-free fixative is recommended. Where PNS neurotoxicity is suspected or likely, at least one (situations 2 and 3) or two (situation 4) nerve cross sections should be postfixed with glutaraldehyde and osmium before hard plastic resin embedding; soft plastic embedding is not a suitable substitute for hard plastic. Special methods may be used if warranted to further characterize PNS findings. Initial PNS analysis should be informed, not masked (“blinded”). Institutions may adapt these recommendations to fit their specific programmatic requirements but may need to explain in project documentation the rationale for their chosen PNS sampling, processing, and evaluation strategy.</description><issn>0192-6233</issn><issn>1533-1601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EotvCnRPysUgN2IkTO9zaCgpSVSKy98hrT7auYjvYDmIfkPfCYQsHJE72zPzzjWZ-hF5R8pZSzt8R2pZNWVVUcF4ywZ6gDa2rqqANoU_RZi0Xa_0Encb4QAgVlJHn6KRsueAV4xv0s992uPPRJOMd7uQM4T3-CspbC06DxlcQE-6CVMkoiHj0AffSzpNx-4uc9zkZf_-l0_jSyekQTcR-xOkecAfBzPcQ5ITvIHz3S8T9ISaw-HyNM2_t6r2VmX4kLMk7b3N0I91-MvIN1kvIA_CddypPNSrDtv6HUSYdcJ8WbSC-QM9GOUV4-fieoe3HD9vrT8Xtl5vP15e3hap4mwoBu7x5U9dE1HrM52CUNFyMoHeMNGWty4ZIpphkolWlBEZbRiUIMTJONavO0PkROwf_bcmHGayJCqZJOsi7DSVh2QpaU56l5ChVwccYYBzmYKwMh4GSYfVu-Ne73PL6kb7sLOi_DX_MyoLiKIhyD8ODX0I-d_w_8BfOqaMc</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Bolon, Brad</creator><creator>Krinke, Georg</creator><creator>Butt, Mark T.</creator><creator>Rao, Deepa B.</creator><creator>Pardo, Ingrid D.</creator><creator>Jortner, Bernard S.</creator><creator>Garman, Robert H.</creator><creator>Jensen, Karl</creator><creator>Andrews-Jones, Lydia</creator><creator>Morrison, James P.</creator><creator>Sharma, Alok K.</creator><creator>Thibodeau, Michael S.</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201806</creationdate><title>STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies</title><author>Bolon, Brad ; Krinke, Georg ; Butt, Mark T. ; Rao, Deepa B. ; Pardo, Ingrid D. ; Jortner, Bernard S. ; Garman, Robert H. ; Jensen, Karl ; Andrews-Jones, Lydia ; Morrison, James P. ; Sharma, Alok K. ; Thibodeau, Michael S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-8eb297655085df001410678fedb40625d260a4c4a489c2ae41941ae88f471d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bolon, Brad</creatorcontrib><creatorcontrib>Krinke, Georg</creatorcontrib><creatorcontrib>Butt, Mark T.</creatorcontrib><creatorcontrib>Rao, Deepa B.</creatorcontrib><creatorcontrib>Pardo, Ingrid D.</creatorcontrib><creatorcontrib>Jortner, Bernard S.</creatorcontrib><creatorcontrib>Garman, Robert H.</creatorcontrib><creatorcontrib>Jensen, Karl</creatorcontrib><creatorcontrib>Andrews-Jones, Lydia</creatorcontrib><creatorcontrib>Morrison, James P.</creatorcontrib><creatorcontrib>Sharma, Alok K.</creatorcontrib><creatorcontrib>Thibodeau, Michael S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Toxicologic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bolon, Brad</au><au>Krinke, Georg</au><au>Butt, Mark T.</au><au>Rao, Deepa B.</au><au>Pardo, Ingrid D.</au><au>Jortner, Bernard S.</au><au>Garman, Robert H.</au><au>Jensen, Karl</au><au>Andrews-Jones, Lydia</au><au>Morrison, James P.</au><au>Sharma, Alok K.</au><au>Thibodeau, Michael S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies</atitle><jtitle>Toxicologic pathology</jtitle><addtitle>Toxicol Pathol</addtitle><date>2018-06</date><risdate>2018</risdate><volume>46</volume><issue>4</issue><spage>372</spage><epage>402</epage><pages>372-402</pages><issn>0192-6233</issn><eissn>1533-1601</eissn><abstract>Peripheral nervous system (PNS) toxicity is surveyed inconsistently in nonclinical general toxicity studies. These Society of Toxicologic Pathology “best practice” recommendations are designed to ensure consistent, efficient, and effective sampling, processing, and evaluation of PNS tissues for four different situations encountered during nonclinical general toxicity (screening) and dedicated neurotoxicity studies. For toxicity studies where neurotoxicity is unknown or not anticipated (situation 1), PNS evaluation may be limited to one sensorimotor spinal nerve. If somatic PNS neurotoxicity is suspected (situation 2), analysis minimally should include three spinal nerves, multiple dorsal root ganglia, and a trigeminal ganglion. If autonomic PNS neuropathy is suspected (situation 3), parasympathetic and sympathetic ganglia should be assessed. For dedicated neurotoxicity studies where a neurotoxic effect is expected (situation 4), PNS sampling follows the strategy for situations 2 and/or 3, as dictated by functional or other compound/target-specific data. For all situations, bilateral sampling with unilateral processing is acceptable. For situations 1–3, PNS is processed conventionally (immersion in buffered formalin, paraffin embedding, and hematoxylin and eosin staining). For situation 4 (and situations 2 and 3 if resources and timing permit), perfusion fixation with methanol-free fixative is recommended. Where PNS neurotoxicity is suspected or likely, at least one (situations 2 and 3) or two (situation 4) nerve cross sections should be postfixed with glutaraldehyde and osmium before hard plastic resin embedding; soft plastic embedding is not a suitable substitute for hard plastic. Special methods may be used if warranted to further characterize PNS findings. Initial PNS analysis should be informed, not masked (“blinded”). Institutions may adapt these recommendations to fit their specific programmatic requirements but may need to explain in project documentation the rationale for their chosen PNS sampling, processing, and evaluation strategy.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>29787347</pmid><doi>10.1177/0192623318772484</doi><tpages>31</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0192-6233
ispartof Toxicologic pathology, 2018-06, Vol.46 (4), p.372-402
issn 0192-6233
1533-1601
language eng
recordid cdi_proquest_miscellaneous_2043181517
source SAGE Complete; Alma/SFX Local Collection
title STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T08%3A40%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=STP%20Position%20Paper:%20Recommended%20Best%20Practices%20for%20Sampling,%20Processing,%20and%20Analysis%20of%20the%20Peripheral%20Nervous%20System%20(Nerves%20and%20Somatic%20and%20Autonomic%20Ganglia)%20during%20Nonclinical%20Toxicity%20Studies&rft.jtitle=Toxicologic%20pathology&rft.au=Bolon,%20Brad&rft.date=2018-06&rft.volume=46&rft.issue=4&rft.spage=372&rft.epage=402&rft.pages=372-402&rft.issn=0192-6233&rft.eissn=1533-1601&rft_id=info:doi/10.1177/0192623318772484&rft_dat=%3Cproquest_cross%3E2043181517%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2043181517&rft_id=info:pmid/29787347&rft_sage_id=10.1177_0192623318772484&rfr_iscdi=true